Company profile: Interpace Biosciences
1.1 - Company Overview
Company description
- Provider of molecular diagnostics and support services: PancraGEN assesses pancreaticobiliary cancer risk via DNA analysis; ThyGeNEXT uses NGS to identify mutations in thyroid nodules; ThyraMIR classifies indeterminate nodules with microRNA; RespriDx differentiates new primary lung tumors from metastases; BarreGen predicts Barrett’s Esophagus progression; NAVIGATOR aids testing access and financing.
Products and services
- ThyGeNEXT: A Next Generation Sequencing-based test that identifies mutations in thyroid nodules to indicate thyroid cancer likelihood
- ThyraMIR: A microRNA-based classifier that assists evaluation of thyroid nodules for cancer risk when traditional cytology is indeterminate
- PancraGEN: A molecular test assessing the risk of pancreaticobiliary cancers from pancreatic cysts and lesions using DNA analysis
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Interpace Biosciences
Oxford Biosystems
HQ: United Kingdom
Website
- Description: Provider of diagnostic and research reagents and instrumentation to laboratories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oxford Biosystems company profile →
Ambu
HQ: Denmark
Website
- Description: Provider of medical devices across anaesthesia, patient monitoring & diagnostics, and emergency care. Founded in 1937, its products are relied on by millions of patients and healthcare professionals worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ambu company profile →
BioCheck
HQ: United States
Website
- Description: Provider of immunodiagnostic test kits and research reagents, and enzyme immunoassay research services and products, offering immunoassay kits for classifications including cardiac markers and tumor classifications; developed, manufactured, and distributed for worldwide healthcare markets, operating an FDA-certified cGMP device-manufacturing facility in Foster City, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioCheck company profile →
Alcor Scientific
HQ: United States
Website
- Description: Provider of diagnostic instrumentation and medical devices, including iSED ELITE and iSED fully automated ESR analyzers delivering results in 20 seconds and miniiSED compact ESR analyzer for low-volume labs; SEDiTROL bi-level human-based whole blood controls; MIZAR rheometer measuring red blood cell deformability, elasticity, and aggregability; and SENTINELplus enteral feeding pump with drop-detection and advanced memory.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alcor Scientific company profile →
Luminex
HQ: United States
Website
- Description: Provider of flow cytometry and imaging, supported by commercial, operations, research and development, and support personnel.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Luminex company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Interpace Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Interpace Biosciences
2.2 - Growth funds investing in similar companies to Interpace Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Interpace Biosciences
4.2 - Public trading comparable groups for Interpace Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →